Class II

Drug Recall: Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Cipla USA, Inc. · October 23, 2024

Reason for Recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Distribution

USA nationwide.

States Affected

NATIONWIDE

Quantity Affected

1,875 boxes (cipla and exlan)

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0043-2025

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.